title: Severe urinary retention requiring urinary catheterization associated with combined treatment of depression with duloxetine and quetiapine.
authors.forename: Sheng-Min
authors.initials: SM
authors.lastname: Wang
authors.forename: Kyoung-Uk
authors.initials: KU
authors.lastname: Lee
authors.forename: Yang-Whan
authors.initials: YW
authors.lastname: Jeon
authors.forename: E-Jin
authors.initials: EJ
authors.lastname: Park
authors.forename: Sang-Ick
authors.initials: SI
authors.lastname: Han
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000150:complications* / Q000188:drug therapy*; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D000068736:Duloxetine Hydrochloride; D006801:Humans; D008297:Male; D000069348:Quetiapine Fumarate; D013876:Thiophenes / Q000009:adverse effects* / Q000627:therapeutic use*; D014546:Urinary Catheterization; D016055:Urinary Retention / Q000139:chemically induced* / Q000628:therapy*
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D013876:Thiophenes; D000069348:Quetiapine Fumarate; D000068736:Duloxetine Hydrochloride